These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

149 related items for PubMed ID: 24751043

  • 1. Albizia procera gum as an excipient for oral controlled release matrix tablet.
    Pachuau L, Mazumder B.
    Carbohydr Polym; 2012 Sep 01; 90(1):289-95. PubMed ID: 24751043
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Evaluation of Albizia procera gum as compression coating material for colonic delivery of budesonide.
    Pachuau L, Mazumder B.
    Int J Biol Macromol; 2013 Oct 01; 61():333-9. PubMed ID: 23916644
    [Abstract] [Full Text] [Related]

  • 4. Design and development of Albizia stipulata gum based controlled-release matrix tablets in cancer therapeutics.
    T VS, Henry LJ, Narra K, Lalduhsanga P, Kandasamy R.
    Int J Biol Macromol; 2016 Nov 01; 92():972-980. PubMed ID: 27506120
    [Abstract] [Full Text] [Related]

  • 5. Gum Ghatti--a pharmaceutical excipient: development, evaluation and optimization of sustained release mucoadhesive matrix tablets of domperidone.
    Gurpreetarora, Malik K, Rana V, Singh I.
    Acta Pol Pharm; 2012 Nov 01; 69(4):725-37. PubMed ID: 22876617
    [Abstract] [Full Text] [Related]

  • 6. Matrix properties of a new plant gum in controlled drug delivery.
    Kalu VD, Odeniyi MA, Jaiyeoba KT.
    Arch Pharm Res; 2007 Jul 01; 30(7):884-9. PubMed ID: 17703742
    [Abstract] [Full Text] [Related]

  • 7. Exploring the Effectiveness of Carboxymethylated and Crosslinked Albizia procera Gum in Diltiazem Hydrochloride Matrix Tablets: A Comparative Analysis.
    Mukherjee S, Khanam J.
    Chem Pharm Bull (Tokyo); 2024 May 09; 72(5):454-470. PubMed ID: 38644216
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Terminalia gum as a directly compressible excipient for controlled drug delivery.
    Bamiro OA, Odeku OA, Sinha VR, Kumar R.
    AAPS PharmSciTech; 2012 Mar 09; 13(1):16-23. PubMed ID: 22068290
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Assessment of Albizia zygia gum as a binding agent in tablet formulations.
    Odeku OA.
    Acta Pharm; 2005 Sep 09; 55(3):263-76. PubMed ID: 16375837
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Comparative studies of binding potential of Prunus armeniaca and Prunus domestica gums in tablets formulations.
    Rahim H, Khan MA, Sadiq A, Khan S, Chishti KA, Rahman IU.
    Pak J Pharm Sci; 2015 May 09; 28(3):909-14. PubMed ID: 26004724
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Formulation and evaluation of mucoadhesive matrix tablets of taro gum: optimization using response surface methodology.
    Arora G, Malik K, Singh I.
    Polim Med; 2011 May 09; 41(2):23-34. PubMed ID: 21866794
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.